Tag: Lupin Pharmaceuticals

Lupin Pharmaceuticals gets FDA approval for SOLOSEC sNDA

pallavi123- February 20, 2022

Lupin Pharmaceuticals has secured approval from the US Food and Drug Administration for its supplemental new drug application (sNDA) to expand the indication of SOLOSEC ... Read More

Lupin Pharmaceuticals signs agreement with Exeltis to promote Solosec in US

pallavi123- January 27, 2022

Indian pharma company Lupin Pharmaceuticals has signed an agreement with Exeltis USA to promote its antimicrobial drug Solosec (secnidazole) in the US market. Solosec is ... Read More